Aptevo Therapeutics (APVO) Short-term Investments (2016 - 2021)

Aptevo Therapeutics has reported Short-term Investments for 6 years, with the latest figure at $1.3 million in Q3 2021.

• Quarterly Short-term Investments fell 50.72% year-over-year to $1.3 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $1.3 million (down 50.72% YoY) and the FY2020 annual result came in at $2.6 million, changed N/A from the prior year.
• Short-term Investments held at $1.3 million in Q3 2021 per APVO's latest filing, from $1.3 million in the prior quarter.
• Over five years, Short-term Investments peaked at $49.8 million in Q1 2018 and troughed at $400000.0 in Q4 2017.
• A 5-year average of $14.0 million and a median of $7.4 million in 2018 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2017 and 2018: Short-term Investments tumbled 99.11% in 2017, then surged 1762.0% in 2018.
• Over 5 years, Short-term Investments stood at $400000.0 in 2017, then soared by 1762.0% to $7.4 million in 2018, then climbed by 0.67% to $7.5 million in 2019, then sank by 65.92% to $2.6 million in 2020, then tumbled by 50.72% to $1.3 million in 2021.
• According to Business Quant data, Short-term Investments over the past three periods registered $1.3 million, $1.3 million, and $1.3 million for Q3 2021, Q2 2021, and Q1 2021 respectively.